Coloplast Q4 Profit Rises 36%, Revenue Up 7%; Issues FY27 Guidance
The Danish medical-device maker said fourth-quarter profit increased 36% and revenue rose 7%, citing performance in Chronic Care and Interventional Urology. The body is truncated before guidance details.
BRUSSELS (dpa-AFX) - Coloplast A/S (COLO-B.CO, CLPBY, COLOb.CO), a Danish medical devices manufacturer, Wednesday said that its fourth-quarter profit rose 36 percent, helped by good performance by the Chronic Care and Interventional Urology divisions. The company also released its outlook for fisca…